Humana: Full-Year Adjusted EPS Guidance Raised To At Least $9.50

Humana raised its full-year 2026 adjusted earnings guidance after reporting third-quarter GAAP earnings of $1.33 per diluted share. The health insurer now expects adjusted earnings of at least $9.50 per share, up from its previous forecast of at least $9, while GAAP earnings guidance increased to at least $15.09 per share from at least $6.52.

Third-quarter income before taxes was $216 million, compared with $134 million a year earlier. On an adjusted basis, Humana recorded a pre-tax loss of $104 million, compared with adjusted pre-tax income of $527 million in the prior-year quarter. Adjusted loss per share was $0.70, versus adjusted earnings of $3.24 per share a year earlier. The large difference between GAAP and adjusted results included valuation changes associated with nonconsolidated minority investments and costs connected with value-creation initiatives.

For the first nine months of 2026, GAAP earnings were $16.84 per diluted share, compared with $16.43 in the prior-year period. Adjusted earnings were $17.17 per share, down from $21.10. Humana said the full-year adjusted outlook still reflects a year-over-year decline caused by the 2026 Star Ratings headwind, net of mitigation measures.

The company reported Medicaid membership growth of 103,600, or 7%, during the year to date. The increase was driven largely by the start of integrated programs serving people eligible for both Medicare and Medicaid in Michigan, Illinois, and South Carolina. Humana also indicated that its benefit-expense ratio was tracking slightly above 94%, consistent with management’s expectations.

The raised adjusted EPS floor suggests improved confidence in execution through year-end, even as the company manages pressure from Star Ratings and changes across its insurance and CenterWell operations. Humana’s updated GAAP forecast also reflects valuation adjustments and other items that can create substantial differences between reported and adjusted performance.

KEY QUOTE:

“Humana is delivering positive results for our members, our patients and their health. We are also increasingly driving financial and operating performance toward being ahead of our plan.”

Jim Rechtin, President and Chief Executive Officer of Humana